after HIPAA violation, my data rights?
|
| Post date: 2020-10-23 08:36:01 |
| Views: 200 |
Keystone Shops, a medical marijuana dispensary chain in PA, sent out an email yesterday to 266 patients with all 266 of our emails in the To field (many with full names also listed next to the email address). They haven't acknowledged this in any way – which in a sense is even worse than the breach itself and what it means about their standards for storing and working with patient data. What are my rights now regarding my own data?
Especially, if I want to stop being their patient because of this, do I have the right to make them delete all my contact info from all their means of storage? I would never trust Keystone's own word on data after this, but is there an external way – under HIPAA or otherwise – to force them to documentably comply with an individual patient's info-deletion request?
Beyond feeling violated, I feel shocked they don't even think this privacy breach is worth any acknowledgment. But the worst feeling is that I have no way out of my relationship with the company if they have all my data and could casually share my info again at any time. :( |
| Please click Here to read the full story. |
| |
| Other Top and Latest Questions: |
United Arab Emirates' 'Spy Sheikh' bought secret stake in Trump crypto company: WSJ
|
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation
|
Barclays AAdvantage cards are moving to Citi: What cardholders should know
|
Rare earth miners jump as Trump is eyeing mineral stockpile to reduce China dependence
|
Answered: I'll be taking custom jobs/orders for Q2A
|
Strategy slides after bitcoin briefly dips below crypto firm's key breakeven level
|
Trump says U.S. and India reached trade deal, will lower tariffs immediately
|
From Clawdbot to Moltbot to OpenClaw: Meet the AI agent generating buzz and fear globally
|
Uber reports 20% revenue growth in fourth-quarter, fueled by food delivery
|
Get the first look at the R2, Rivian's $45,000 SUV. CEO RJ Scaringe gave CNBC an early peek
|